These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29672108)

  • 41. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
    Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Albizia zygia root extract exhibits antipsychotic-like properties in murine models of schizophrenia.
    Kumbol VW; Abotsi WKM; Ekuadzi E; Woode E
    Biomed Pharmacother; 2018 Oct; 106():831-841. PubMed ID: 30119253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Olfactory and gustatory stimuli in food-aversion learning of rats.
    Schneider K; Pinnow M
    J Gen Psychol; 1994 Apr; 121(2):169-83. PubMed ID: 8083674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Course and symptom and functional correlates of passivity symptoms in schizophrenia: an 18-year multi-follow-up longitudinal study.
    Herbener ES; Harrow M
    Psychol Med; 2021 Feb; 51(3):503-510. PubMed ID: 31839019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex.
    Cloke JM; Nguyen R; Chung BY; Wasserman DI; De Lisio S; Kim JC; Bailey CD; Winters BD
    J Neurosci; 2016 Dec; 36(50):12570-12585. PubMed ID: 27974613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diosmin attenuates schizophrenia-like behavior, oxidative stress, and acetylcholinesterase activity in mice.
    Okubo Eneni AE; Ben-Azu B; Mayowa Ajayi A; Oladele Aderibigbe A
    Drug Metab Pers Ther; 2020 Oct; 35(4):. PubMed ID: 34704698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways.
    George MY; Menze ET; Esmat A; Tadros MG; El-Demerdash E
    Life Sci; 2020 May; 249():117535. PubMed ID: 32151688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats.
    McIntosh AL; Ballard TM; Steward LJ; Moran PM; Fone KC
    Psychopharmacology (Berl); 2013 Jul; 228(1):31-42. PubMed ID: 23397053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Representation-mediated Aversion as a Model to Study Psychotic-like States in Mice.
    Busquets-Garcia A; Soria-Gómez E; Ferreira G; Marsicano G
    Bio Protoc; 2017 Jun; 7(12):. PubMed ID: 29094060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.
    Brown JW; Whitehead CA; Basso AM; Rueter LE; Zhang M
    Int J Neuropsychopharmacol; 2013 May; 16(4):889-904. PubMed ID: 22906530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.
    Koh MT; Shao Y; Sherwood A; Smith DR
    Schizophr Res; 2016 Mar; 171(1-3):187-94. PubMed ID: 26811256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
    Noda Y; Yamada K; Furukawa H; Nabeshima T
    Br J Pharmacol; 1995 Nov; 116(5):2531-7. PubMed ID: 8581295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Taste-potentiated odor aversion learning based on amphetamine.
    Bryant PA; Boakes RA; McGregor IS
    Physiol Behav; 1993 Aug; 54(2):393-8. PubMed ID: 8396783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
    Kandratavicius L; Balista PA; Wolf DC; Abrao J; Evora PR; Rodrigues AJ; Chaves C; Maia-de-Oliveira JP; Leite JP; Dursun SM; Baker GB; Guimaraes FS; Hallak JE
    BMC Neurosci; 2015 Mar; 16():9. PubMed ID: 25887360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Odor-avoidance or odor-preference induced by amphetamine in the infant rat depending on the dose and testing modality.
    Revillo DA; Fernandez G; Castello S; Paglini MG; Arias C
    Behav Brain Res; 2012 May; 231(1):201-7. PubMed ID: 22465170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effects of Spinacia oleracea seeds extract in an experimental model of schizophrenia: Possible behavior, biochemical, neurochemical and cellular alterations.
    Yadav M; Parle M; Sharma N; Jindal DK; Bhidhasra A; Dhingra MS; Kumar A; Dhingra S
    Biomed Pharmacother; 2018 Sep; 105():1015-1025. PubMed ID: 30021336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia.
    Maehara S; Hikichi H; Satow A; Okuda S; Ohta H
    Pharmacol Biochem Behav; 2008 Nov; 91(1):140-9. PubMed ID: 18651995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.
    Kapur S
    Am J Psychiatry; 2003 Jan; 160(1):13-23. PubMed ID: 12505794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug treatment of schizophrenia and delusional disorder in late life.
    Howard R
    Int Psychogeriatr; 1996; 8(4):597-608. PubMed ID: 9147173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.